Interview With Lupin Global CFO On Strong Q2 Earnings And Outlook

Pharmaceutical major Lupin reported strong Q2 earnings, with a net profit of ₹490 crore in the second quarter of FY24. This represents a 277 percent increase compared to ₹130 crore in the year-ago period. Additionally, its total revenue from operations came in at ₹5,039 crore in the second quarter, marking a 21 percent increase compared to ₹4,146 crore year-on-year. Join Sakshi Batra in a conversation with Ramesh Swaminathan, ED, Global CFO & Head of Corporate Affairs at Lupin, as they discuss the robust quarterly results and the company's outlook going forward.